Participation of renal and circulating endothelin in salt-sensitive essential hypertension

Journal of Human Hypertension

Volumn 16, Issue 7, 2002, Pages 459-467

  Elijovich, Fernando ^a   Laffer, C L ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Blood pressure; Endothelin; Salt; Salt sensitivity

Indexed keywords

ENDOTHELIN; BOSENTAN; CYCLOSPORIN; DIURETIC AGENT; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; ERYTHROPOIETIN; NATRIURETIC FACTOR; SODIUM CHLORIDE;

BLOOD PRESSURE; DRUG EFFECT; ELECTROLYTE BALANCE; HUMAN; HYPERTENSION; KIDNEY; KIDNEY CIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SALT INTAKE; ANTIHYPERTENSIVE ACTIVITY; BIOCHEMISTRY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; ESSENTIAL HYPERTENSION; EXPERIMENTAL MODEL; KIDNEY TRANSPLANTATION; MEDICAL RESEARCH; METABOLIC REGULATION; NONHUMAN; PHENOTYPE; PREDICTION; PROTEIN URINE LEVEL; RECEPTOR BINDING; RENOVASCULAR HYPERTENSION; SALT LOADING; SODIUM BALANCE; VASODILATATION; VASOSPASM;

BLOOD PRESSURE; ENDOTHELINS; HUMANS; HYPERTENSION; KIDNEY; RENAL CIRCULATION; SODIUM CHLORIDE, DIETARY; WATER-ELECTROLYTE BALANCE; HUMAN;

EID: 0035984995     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001419     Document Type: Review

References (103)

1. Sodium and volume sensitivity of blood pressure: Age and pressure change over time
2. A comparison of two tests for the assessment of blood pressure responses to sodium
3. An approach to the evaluation of genetic influences on factors that regulate arterial blood pressure in man
4. Definitions and characteristics of sodium sensitivity and blood pressure resistance
5. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension
6. Salt sensitivity: Definition, conception, methodology, and long-term issues
7. Interaction of sodium sensitivity and stress in young adults
8. Rise of blood pressure with age: New evidence of population differences
9. Parallel adrenal and renal abnormalities in young patients with essential hypertension
10. Urinary kallikrein and salt sensitivity in essential hypertensive males
11. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients
12. Role of vasopressin in essential hypertension: Racial differences
13. A gender difference in the association between salt sensitivity and family history of hypertension
14. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension
15. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension
16. Insulin resistance in hypertensives: Effect of salt sensitivity, renin status and sodium intake
17. Early abnormalities in left ventricular diastolic function of sodium-sensitive hypertensive patients
18. Sodium sensitivity and cardiovascular events in patients with essential hypertension
19. Association between salt sensitivity and target organ damage in essential hypertension
20. Salt sensitivity in hypertension: Renal and cardiovascular implications
21. Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors
22. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans
23. Salt and hypertension at the close of the millennium
24. Possible mechanisms of salt-induced hypertension in Dahl salt-sensitive rats
25. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension
26. Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat
27. Renal cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats
28. Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity
29. Adducin in essential hypertension
30. The role of the 11 beta-hydroxysteroid dehydrogenase type 2 in human hypertension
31. G-protein beta3 subunit 825T allele and response to dietary salt in normotensive men
32. Salt-sensitive hypertension induced by sensory denervation: Introduction of a new model
33. Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension
34. Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition
35. Effects of sodium intake on the pressor and renal responses to nitric oxide synthesis inhibition in normotensive individuals with different sodium sensitivity
36. Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats
37. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension
38. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats
39. Genetic mapping of soluble guanylyl cyclase genes: Implications for linkage to blood pressure in the Dahl rat
40. Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients
41. Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension
42. Beta 2-adrenoceptor density in fibroblast culture correlates with human NaCl sensitivity
43. A comparison of the antihypertensive potency of kidneys from one strain of rats susceptible to salt hypertension and kidneys from another strain resistant to it
44. Genetic influence of the kidneys on blood pressure: Evidence from chronic renal homografts in rats with opposite predispositions to hypertension
45. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats
46. Role of blood volume expansion in Dahl rat model of hypertension
47. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
48. Endothelin: Potential role in hypertension and vascular hypertrophy
49. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin
50. Effects of endothelin on peptide-dependent cyclic adenosine monophosphate accumulation along the nephron segments of the rat
51. Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renal tubular epithelial cells
52. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
53. Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice
54. Endothelin: New discoveries and rapid progress in the clinic
55. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats
56. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension
57. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
58. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension
59. Role of endothelin in the increased vascular tone of patients with essential hypertension
60. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans
61. A receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men
62. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men
63. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension
64. Endothelin-1 and its mRNA in the wall layers of human arteries ex-vivo
65. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators
66. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats
67. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist
68. A receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats
69. Structure and function of small arteries in salt-induced hypertension
70. A endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats
71. Angiotensin II increases tissue endothelin and induces vascular hypertrophy: Reversal by ET(A)-receptor antagonist
72. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes
73. Plasma levels of endothelin in chronic renal failure and after renal transplantation: Impact on hypertension and cyclosporin A-associated nephrotoxicity
74. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients
75. Effects of obstructive sleep apnea on endothelin-1 and blood pressure
76. Endothelin, elastase, and endothelial dysfunction in pre-eclampsia
77. Urinary and plasma endothelin 1 in essential hypertension and in hypertension secondary to renoparenchymal disease
78. Endothelin in chronic renal failure
79. Hypertension associated with endothelin-secreting malignant hemangioendothelioma
80. Increased plasma endothelin level in patients with essential hypertension
81. Plasma immunoreactive endothelin in essential hypertension
82. Plasma endothelin in human essential hypertension
83. Plasma endothelin levels in hypertension and chronic renal failure
84. Regulation of plasma endothelin by salt in salt-sensitive hypertension
85. Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension
86. High plasma endothelin-1 levels in hypertensive patients with low-renin essential hypertension
87. Central obesity and hypertension: The role of plasma endothelin
88. Comparison of the serum insulin and endothelin level in patients with essential and renovascular hypertension
89. Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: Influence of dietary sodium load and depletion
90. Role of neutral endopeptidase in the metabolism of endothelin
91. Increased renal endothelin production in rats with renal mass reduction
92. Urinary endothelin and sodium excretion in essential hypertension
93. Circadian rhythm of urinary endothelin-1 excretion in mild hypertensive patients
94. Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension
95. Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension
96. Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity
97. Elevated plasma and urinary endothelin-1 levels in human salt-sensitive hypertension
98. Alterations in renal endothelin-1 production in the spontaneously hypertensive rat
99. Immunoreactive endothelin in rat kidney inner medulla: Marked decrease in spontaneously hypertensive rats
100. Polar secretion of endothelin-1 by cultured endothelial cells
101. Plasma endothelin during upright tilt: Relevance for orthostatic hypotension?
102. Endothelial dysfunction in salt-sensitive essential hypertension
103. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist